Ethypharm is a finished-dose manufacturer based in France. It appears in 497 regulatory filings across 20 regulators, without an active US DMF or CEP on file. Its filings concentrate with MHRA (UK), MPA (SE) and EMA. Its GMP standing is certified by ANSM (FR), ZLG (DE) and EMA, among 5 authorities. Its most recent recorded inspection, by US FDA, closed on 25 March 2023 as VAI.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Schönefeld, Germany | Not on file |
| Chateauneuf-En-Thymerais, France | Not on file |
| CHÂTEAUNEUF-EN-THYMERAIS, France | Not on file |
| France, France | 3002807933 |
| Chateauneuf En Thymerais, France | Not on file |
| France, France | 3004715600 |
2 further sites are on record.
| Regulator | Filings | GMP certificates |
|---|---|---|
| MHRA (UK) | 173 | None |
| MPA (SE) | 71 | None |
| EMA | 69 | 2 |
| INFARMED (PT) | 46 | None |
| AIFA (IT) | 43 | None |
| ANSM (FR) | 36 | 10 |
| ZLG (DE) | None | 2 |
| TMDA (TZ) | None | 2 |
| NAFDAC (NG) | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2024 | $145.8M | Not reported | Not reported |
Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.
Choose your molecules and target markets. Ethypharm comes back tiered against every other supplier able to file there.
Start for free